Medication Reconciliation in Oncologic Patients (PROF2)

Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori

Status: Completed

Conditions: Medication Reconciliation

Treatments: Other: medication reconciliation

Study type: Interventional

Funder types: Other

Identifiers

NCT04796142

IRST 100.40

Details and patient eligibility

About

To improve medication reconciliation in oncologic patients in healthcare transitions through an alliance between a Cancer Institute and the community pharmacies and a new integrated IT platform.

Full description

This trial will explore the alliance between a Cancer Institute and the community pharmacies to improve medication reconciliation in healthcare transitions, and will validate a new integrated IT platform.

Cancer patients receiving an oncologic treatment will be asked to choose a pharmacy participating to the trial, and to perform the pharmacological survey before every cycle of chemotherapy.

This will be sent through the new IT platform to the electronic medical record of IRST, and the Oncologist will perform the reconciliation.

Data about concomitant medications and possible interactions will be exensively analyzed.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult ≥18 years old
• Eastern Cooperative Oncology Group (ECOG) performance status ≤1
• Patients receiving an anticancer treatment
• Clear understanding of the Italian language; written informed consent.

Exclusion criteria

• None

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Reconciliation

Experimental group

Description:

Interventional trial without drugs

Treatment:

Other: medication reconciliation